Sale!

GLENVAS 4MG

LENVATINIB

MRP : MRP 1,115.63
Price : 750.00
You Save : 365.63 (32.77%)

10 Capsule(s) In A Strip

Buy Now

Glenvas 4mg Capsule contains Lenvatinib as its active ingredient. This medication is a tyrosine kinase inhibitor used for treating progressive or advanced thyroid cancer when radioactive iodine therapy is ineffective. Additionally, it is prescribed for liver cancer patients who have not received prior treatment and are not candidates for surgical intervention.

Anaplastic Thyroid Carcinoma, a form of advanced thyroid cancer, typically affects individuals over the age of 60. This condition is marked by an enlarged, hardened thyroid gland and voice hoarseness resulting from nerve paralysis in the larynx. Hepatocellular carcinoma, or liver cancer, often arises from existing liver issues such as cirrhosis or chronic hepatitis B infection. Individuals with a history of allergic reactions to Glenvas 4mg Capsule or any of its ingredients should avoid using this medication. It is important for patients to notify their dentist or oral surgeon about their use of Glenvas 4mg Capsule, as it may hinder wound healing and elevate the risk of bleeding.